0000950170-25-071627.txt : 20250514 0000950170-25-071627.hdr.sgml : 20250514 20250514172516 ACCESSION NUMBER: 0000950170-25-071627 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250512 FILED AS OF DATE: 20250514 DATE AS OF CHANGE: 20250514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: J.H. Whitney Equity Partners VII, LLC CENTRAL INDEX KEY: 0001567459 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40362 FILM NUMBER: 25947230 BUSINESS ADDRESS: STREET 1: 212 ELM STREET CITY: NEW CANAAN STATE: CT ZIP: 06840 BUSINESS PHONE: 2037166100 MAIL ADDRESS: STREET 1: 212 ELM STREET CITY: NEW CANAAN STATE: CT ZIP: 06840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aveanna Healthcare Holdings, Inc. CENTRAL INDEX KEY: 0001832332 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 844717209 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 400 INTERSTATE NORTH PARKWAY STREET 2: STE 1700 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 770-441-1580 MAIL ADDRESS: STREET 1: 400 INTERSTATE NORTH PARKWAY STREET 2: STE 1700 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 ownership.xml 4 X0508 4 2025-05-12 0001832332 Aveanna Healthcare Holdings, Inc. AVAH 0001567459 J.H. Whitney Equity Partners VII, LLC 212 ELM STREET NEW CANAAN CT 06840 false false true false true Common Stock, $0.01 par value 0 D Common Stock, $0.01 par value 2025-05-12 4 S false 30429 5.72 D 31288975 I By J.H. Whitney VII, L.P. Common Stock, $0.01 par value 2025-05-13 4 S false 27883 5.86 D 31261092 I By J.H. Whitney VII, L.P. Common Stock, $0.01 par value 2025-05-12 4 S false 15203 5.72 D 15632307 I By PSA Healthcare Investment Holding LLC Common Stock, $0.01 par value 2025-05-13 4 S false 13930 5.86 D 15618377 I By PSA Healthcare Investment Holding LLC Common Stock, $0.01 par value 2025-05-12 4 S false 1407 5.72 D 1447191 I By PSA Iliad Holdings LLC Common Stock, $0.01 par value 2025-05-13 4 S false 1290 5.86 D 1445901 I By PSA Iliad Holdings LLC The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC, PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities") and JHW Iliad Holdings II LLC on December 13, 2024. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.62 to $5.84. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.84 to $5.89. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare, and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. /s/ David Zatlukal, Attorney-in-Fact 2025-05-14